KR970021079A - N- (2-fluorocyclopropyl) -substituted quinolinecarboxylic acid derivatives - Google Patents

N- (2-fluorocyclopropyl) -substituted quinolinecarboxylic acid derivatives Download PDF

Info

Publication number
KR970021079A
KR970021079A KR1019950033896A KR19950033896A KR970021079A KR 970021079 A KR970021079 A KR 970021079A KR 1019950033896 A KR1019950033896 A KR 1019950033896A KR 19950033896 A KR19950033896 A KR 19950033896A KR 970021079 A KR970021079 A KR 970021079A
Authority
KR
South Korea
Prior art keywords
compound
formula
group
quinolinecarboxylic acid
protected
Prior art date
Application number
KR1019950033896A
Other languages
Korean (ko)
Inventor
김문식
배현섭
태현섭
하형호
Original Assignee
김정규
주식회사 씨앤드씨 신약연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김정규, 주식회사 씨앤드씨 신약연구소 filed Critical 김정규
Priority to KR1019950033896A priority Critical patent/KR970021079A/en
Publication of KR970021079A publication Critical patent/KR970021079A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

본 발명은 향균제로 유용한 퀴놀린카르복실산 유도체 및 그의 제조방법에 관한 것이다. 더욱 구체적으로, 본 발명은 플루오로퀴놀린카르복실산의 1번 위치에 2-플루오로사이클로프로필 그룹을 갖는 다음 일반식(I)로 표시되는 퀴놀린카르복실산 유도체 및 그의 염, 이들의 제조방법 및 이들 화합물을 활성성분으로 함유하는항균제 조성물에 관한 것이다.The present invention relates to quinolinecarboxylic acid derivatives useful as antibacterial agents and methods for their preparation. More specifically, the present invention provides a quinolinecarboxylic acid derivative represented by the following general formula (I) having a 2-fluorocyclopropyl group at position 1 of the fluoroquinolinecarboxylic acid and salts thereof, a method for preparing the same, and An antimicrobial composition containing these compounds as an active ingredient.

상기 식에서, R1은 수소 원자, 할로겐 원자, 알콕시 그룹, 보호되거나 비보호된 하이드록실 그룹, 보호되거나 비보호된 아미노 그룹, 보호되거나 비보호된 저급알킬아미노 그룹, 또는 디-저급알킬아미노 그룹을 나타내고, A는 질소 원자 또는 C-R2를 나타내고, 여기에서 R2는 수소 원자, 할로겐 원자, 아미노 그룹, 저급알킬 그룹 또는 저급알콕시 그룹을 나타내며, n은 1 내지 4의 정수를 나타낸다.Wherein R 1 represents a hydrogen atom, a halogen atom, an alkoxy group, a protected or unprotected hydroxyl group, a protected or unprotected amino group, a protected or unprotected lower alkylamino group, or a di-lower alkylamino group, A Represents a nitrogen atom or CR 2 , wherein R 2 represents a hydrogen atom, a halogen atom, an amino group, a lower alkyl group or a lower alkoxy group, and n represents an integer of 1 to 4.

Description

N-(2-플루오로사이클로프로필)-치환된 퀴놀린카르복실산 유도체N- (2-fluorocyclopropyl) -substituted quinolinecarboxylic acid derivatives

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (13)

하기 일반식(I)의 퀴놀린카르복실산 유도체 및 그의 염 :Quinolinecarboxylic acid derivatives of the general formula (I) and salts thereof: 상기 식에서, R1은 수소 원자, 할로겐 원자, 알콕시 그룹, 보호되거나 비보호된 하이드록실 그룹, 보호되거나 비보호된 아미노 그룹, 보호되거나 비보호된 저급알킬아미노 그룹, 또는 디-저급알킬아미노 그룹을 나타내고, A는 질소 원자 또는 C-R2를 나타내고, 여기에서 R2는 수소 원자, 할로겐 원자, 아미노 그룹, 저급알킬 그룹 또는 알콕시 그룹을 나타내며, n은 1 내지 4의 정수를 나타낸다.Wherein R 1 represents a hydrogen atom, a halogen atom, an alkoxy group, a protected or unprotected hydroxyl group, a protected or unprotected amino group, a protected or unprotected lower alkylamino group, or a di-lower alkylamino group, A Represents a nitrogen atom or CR 2 , wherein R 2 represents a hydrogen atom, a halogen atom, an amino group, a lower alkyl group or an alkoxy group, and n represents an integer of 1 to 4. 제1항에 있어서 R1이 수소 원자를 나타내며, A가 C-R2를 나타내고, 여기에서 R2는 수소 원자, 아미노 그룹 또는 저급 알콕시 그룹을 나타내는 화합물.The compound of claim 1, wherein R 1 represents a hydrogen atom, A represents CR 2 , wherein R 2 represents a hydrogen atom, an amino group or a lower alkoxy group. 제2항에 있어서, 7-(1-아미노사이클로프로필)-1-[(1R*,2S*)-2-플루오로사이 클로프로필]-6-플루오로-8-메톡시-1.4-디하이드로-4-옥소-3-퀴놀린카르복실산인 화합물.The compound of claim 2, wherein 7- (1-aminocyclopropyl) -1-[(1R * , 2S * )-2-fluorocycloclopropyl] -6-fluoro-8-methoxy-1.4-dihydro 4-oxo-3-quinolinecarboxylic acid. 일반식(10)의 화합물 또는 그의 염을 산화시켜 일반식(11)의 화합물 또는 그의 염을 생성시키고, 생성된 일반식(11)의 화합물 또는 그의 염에 대해 호프만 전위반응을 수행함을 특징으로 하여, 일반식(I)의 퀴놀린카르복실산 유도체 또는 그의 염을 제조하는 방법.By oxidizing the compound of formula (10) or a salt thereof to produce a compound of formula (11) or a salt thereof, and performing a Hoffman potential reaction on the resulting compound of formula (11) or a salt thereof And a method for producing a quinolinecarboxylic acid derivative of formula (I) or a salt thereof. 상기 식에서, R1, A 및 n은 제1항에서 정의한 바와 같다.Wherein R 1 , A and n are as defined in claim 1. 제4항에 있어서, 산화반응을 무기산을 사용하여 수행함을 특징으로 하는 방법.The method according to claim 4, wherein the oxidation reaction is carried out using an inorganic acid. 제5항에 있어서 무기산으로 황산 또는 염산을 사용함을 특징으로 하는 방법.The method according to claim 5, wherein sulfuric acid or hydrochloric acid is used as the inorganic acid. 제4항에 있어서, 호프만 전위반응을 나트륨하이포클로라이드 또는 나트륨 하이포브로마이드의 존재하에서 수행함을 특징으로 하는 방법.5. The method of claim 4, wherein the Hoffman dislocation reaction is carried out in the presence of sodium hypochloride or sodium hypobromide. 약제학적으로 허용되는 담체와 함께 활성성분으로서 제1항에 따르는 일반식(I)의 퀴놀린카르복실산 유도체 또는 그의 염을 함유함을 특징으로 하는 항균제 조성물.An antimicrobial composition comprising a quinolinecarboxylic acid derivative of formula (I) according to claim 1 or a salt thereof as an active ingredient together with a pharmaceutically acceptable carrier. 하기 일반식(11)의 화합물 :Compound of the following general formula (11): 상기 식에서, R1, A 및 n은 제1항에서 정의한 바와 같다.Wherein R 1 , A and n are as defined in claim 1. 하기 일반식(10)의 화합물 :Compound of the following general formula (10): 상기 식에서, R1, A 및 n은 제1항에서 정의한 바와 같다.Wherein R 1 , A and n are as defined in claim 1. (1) 일반식(7)의 화합물을 염기의 존재하에서 2-플루오로사이클로프로필아민 염산염과 반응시켜 일반식(8)의 화합물을 수득하고; (2) 생성된 일반식(8)의 화합물을 염기의 존재하에서 폐환시켜 일반식(9)의 화합물을 제조한 후; (3) 일반식(9)의 화합물을 가수분해시킴을 특징으로 하여, 일반식(10)의 화합물을 제조하는 방법:(1) reacting a compound of formula (7) with 2-fluorocyclopropylamine hydrochloride in the presence of a base to give a compound of formula (8); (2) closing the resulting compound of formula (8) in the presence of a base to prepare a compound of formula (9); (3) A process for preparing the compound of formula (10), characterized by hydrolyzing the compound of formula (9): 상기 식에서, R1, A 및 n은 제1항에서 정의한 바와 같고, X는 할로겐 원자를 나타낸다.Wherein R 1 , A and n are as defined in claim 1 and X represents a halogen atom. 하기 일반식(9)의 화합물 :Compound of the following general formula (9): 상기 식에서, R1, A 및 n은 제1항에서 정의한 바와 같다.Wherein R 1 , A and n are as defined in claim 1. 하기 일반식(8)의 화합물 :Compound of the following general formula (8): 상기 식에서, R1, A 및 n은 제1항에서 정의한 바와 같고, X는 할로겐 원자를 나타낸다.Wherein R 1 , A and n are as defined in claim 1 and X represents a halogen atom. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950033896A 1995-10-04 1995-10-04 N- (2-fluorocyclopropyl) -substituted quinolinecarboxylic acid derivatives KR970021079A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950033896A KR970021079A (en) 1995-10-04 1995-10-04 N- (2-fluorocyclopropyl) -substituted quinolinecarboxylic acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950033896A KR970021079A (en) 1995-10-04 1995-10-04 N- (2-fluorocyclopropyl) -substituted quinolinecarboxylic acid derivatives

Publications (1)

Publication Number Publication Date
KR970021079A true KR970021079A (en) 1997-05-28

Family

ID=66583521

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950033896A KR970021079A (en) 1995-10-04 1995-10-04 N- (2-fluorocyclopropyl) -substituted quinolinecarboxylic acid derivatives

Country Status (1)

Country Link
KR (1) KR970021079A (en)

Similar Documents

Publication Publication Date Title
KR900016205A (en) Optically active pyridonecarboxylic acid derivative
DE60228229D1 (en) NEW ADENINE DERIVATIVES
CA2383409A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
HUP0300838A2 (en) Novel heteroaryl derivatives, process for their preparation and the use thereof as pharmaceuticals
KR910000620A (en) N-substituted laurylamide, preparation method thereof
DK96786D0 (en) AMINO ACID DERIVATIVES
KR910004597A (en) 1- (pyridinylamino) -2-pyrrolidinone, preparation method thereof and use thereof as medicament
DK0420121T3 (en) Antitumor agent
KR970021079A (en) N- (2-fluorocyclopropyl) -substituted quinolinecarboxylic acid derivatives
DE60013560D1 (en) MALTO-OLIGOSACCHARID DERIVATIVES AND THEIR APPLICATIONS
DE60009517D1 (en) A-500359 DERIVATIVES
AU655869B2 (en) An amphoteric tricyclic compound
MXPA01007705A (en) Benzamide derivatives and drugs containing the same.
AU8003594A (en) Quinolinecarboxylic acid derivative and salt thereof
KR920006346A (en) 3- (1H-indazol-3-yl) -4-pyridinamine, process for its preparation, intermediate for its preparation and use thereof as a medicament
KR900014407A (en) Quinoline carboxylic acid derivatives and antimicrobial agents containing the same
KR960700050A (en) 2,3-DIHYDROBENZOFURAN DERIVATIVE
EP1333024A4 (en) Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof
ES2100768T3 (en) ACTIVE AGENT ON THE CENTRAL NERVOUS SYSTEM, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
KR910016737A (en) Quinoline derivatives and preparation method thereof
KR910016759A (en) Benzoxazine derivatives and preparation method thereof
KR930002303A (en) N-arylalkyl parahydroxyphenylacetamide derivatives and preparation method thereof
KR960017657A (en) New quinolinecarboxylic acid derivatives and preparation method thereof
KR930016416A (en) 7-substituted piperazinyl amino-3-quinolone carboxylic acid derivatives and preparation method thereof
ATE97902T1 (en) CEPHEM COMPOUNDS AND PROCESSES FOR THEIR PRODUCTION.

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination